JPH04178320A - Production of anticariogenic agent and anticariogenic substance and anticariogenic food containing the same - Google Patents
Production of anticariogenic agent and anticariogenic substance and anticariogenic food containing the sameInfo
- Publication number
- JPH04178320A JPH04178320A JP2301200A JP30120090A JPH04178320A JP H04178320 A JPH04178320 A JP H04178320A JP 2301200 A JP2301200 A JP 2301200A JP 30120090 A JP30120090 A JP 30120090A JP H04178320 A JPH04178320 A JP H04178320A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- tea
- anticariogenic
- caries
- sugar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000170 anti-cariogenic effect Effects 0.000 title claims abstract description 15
- 235000013305 food Nutrition 0.000 title claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 title claims description 22
- 239000000126 substance Substances 0.000 title claims description 14
- 239000000284 extract Substances 0.000 claims abstract description 50
- 235000013616 tea Nutrition 0.000 claims abstract description 40
- 102000000340 Glucosyltransferases Human genes 0.000 claims abstract description 29
- 108010055629 Glucosyltransferases Proteins 0.000 claims abstract description 29
- 239000003463 adsorbent Substances 0.000 claims abstract description 22
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 20
- 238000001179 sorption measurement Methods 0.000 claims abstract description 6
- 235000019225 fermented tea Nutrition 0.000 claims abstract description 4
- 239000003795 chemical substances by application Substances 0.000 claims abstract 6
- 230000000675 anti-caries Effects 0.000 claims description 21
- 239000004480 active ingredient Substances 0.000 claims description 13
- 239000004075 cariostatic agent Substances 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 13
- 241001122767 Theaceae Species 0.000 claims 9
- 244000269722 Thea sinensis Species 0.000 abstract description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 25
- 235000006468 Thea sinensis Nutrition 0.000 abstract description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 23
- 235000020279 black tea Nutrition 0.000 abstract description 16
- 239000000203 mixture Substances 0.000 abstract description 16
- 235000020333 oolong tea Nutrition 0.000 abstract description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract description 5
- 239000002798 polar solvent Substances 0.000 abstract description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 abstract description 2
- 230000009931 harmful effect Effects 0.000 abstract description 2
- 238000013329 compounding Methods 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 235000000346 sugar Nutrition 0.000 description 53
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 21
- 208000002925 dental caries Diseases 0.000 description 19
- 229940092665 tea leaf extract Drugs 0.000 description 18
- 238000012360 testing method Methods 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- 229920001503 Glucan Polymers 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 235000019441 ethanol Nutrition 0.000 description 9
- 238000000605 extraction Methods 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 229930006000 Sucrose Natural products 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 241000194019 Streptococcus mutans Species 0.000 description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 7
- 235000005487 catechin Nutrition 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 6
- -1 and troches Substances 0.000 description 6
- 150000001765 catechin Chemical class 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000600 sorbitol Substances 0.000 description 5
- 235000010356 sorbitol Nutrition 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000004576 sand Substances 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- 244000215068 Acacia senegal Species 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- 208000002064 Dental Plaque Diseases 0.000 description 3
- 229920000084 Gum arabic Polymers 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 3
- 235000010489 acacia gum Nutrition 0.000 description 3
- 239000000205 acacia gum Substances 0.000 description 3
- 230000001013 cariogenic effect Effects 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 229920001429 chelating resin Polymers 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 229960001375 lactose Drugs 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000007505 plaque formation Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 3
- 229940013618 stevioside Drugs 0.000 description 3
- 235000019202 steviosides Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 235000019224 Camellia sinensis var Qingmao Nutrition 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000011950 custard Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
- 235000019797 dipotassium phosphate Nutrition 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000001727 glucose Nutrition 0.000 description 2
- 229960001031 glucose Drugs 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 125000005395 methacrylic acid group Chemical group 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000020339 pu-erh tea Nutrition 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- 238000002525 ultrasonication Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- LSHVYAFMTMFKBA-PZJWPPBQSA-N (+)-catechin-3-O-gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-PZJWPPBQSA-N 0.000 description 1
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 101100313763 Arabidopsis thaliana TIM22-2 gene Proteins 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 241000531735 Pelargonium mutans Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 239000004091 cariogenic agent Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000005115 demineralization Methods 0.000 description 1
- 230000002328 demineralizing effect Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 229910000393 dicalcium diphosphate Inorganic materials 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- 238000012850 discrimination method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 1
- 229940030275 epigallocatechin gallate Drugs 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- LVJJFMLUMNSUFN-UHFFFAOYSA-N gallocatechin gallate Natural products C1=C(O)C=C2OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C1OC(=O)C1=CC(O)=C(O)C(O)=C1 LVJJFMLUMNSUFN-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000009422 growth inhibiting effect Effects 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 235000015094 jam Nutrition 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229940057948 magnesium stearate Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 239000004320 sodium erythorbate Substances 0.000 description 1
- 235000010352 sodium erythorbate Nutrition 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229960000414 sodium fluoride Drugs 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野コ
本発明は抗う蝕剤及び抗う蝕性物質の製造方法に関し、
さらに詳しくは、グルコシルトランスフェラーゼ阻害作
用を有する茶葉からの抽出物を有効成分とする抗う蝕剤
及び茶葉からの抗う蝕性物質の製造方法並びにそれを含
む抗う触性食品に関する
[従来の技術]
う蝕の原因については過去、種々の仮説が提唱されたが
、現在ではミラー(Miller )の化学細菌説に基
づく細菌感染症の一種であると認められている。[Detailed Description of the Invention] [Industrial Application Field] The present invention relates to an anti-caries agent and a method for producing an anti-caries substance,
More specifically, [prior art] relating to an anti-caries agent containing an extract from tea leaves having a glucosyltransferase inhibitory effect as an active ingredient, a method for producing an anti-caries substance from tea leaves, and an anti-caries food containing the same. Although various hypotheses have been proposed in the past regarding the cause of this disease, it is now recognized that it is a type of bacterial infection based on Miller's chemical bacteria theory.
この説に基づくう蝕の発生機構は以下のごとくである。The caries development mechanism based on this theory is as follows.
即ち、口腔連鎖球菌、特にストレプトコッカス・ミュー
タンス(5trepto−coccus mutans
)が産生ずるグルコシルトランスフェラーゼ゛という酵
素が、まず、口中のしょ糖を基質として、粘着性、不溶
性の多糖(グルカン)を生成する。ストレプトコッカス
・ミュータンス(以下、rS、ミュータンス」と略称す
る)の菌体は、生成したグルカンによって、歯表面に付
着して画境(歯垢)を形成する。 この歯垢中ではS、
ミュータンスを始め種々の微生物が共生、繁殖している
が、これら微生物の代謝によって有機酸が産生され、こ
の有機酸の作用で歯表面のpHが低下し、エナメル質表
面に脱灰が生じて、う蝕が発生し、進行する。That is, oral streptococci, especially Streptococcus mutans
) produces an enzyme called glucosyltransferase, which first uses sucrose in the mouth as a substrate to produce a sticky, insoluble polysaccharide (glucan). Bacterial cells of Streptococcus mutans (hereinafter abbreviated as rS, mutans) adhere to the tooth surface and form plaque (dental plaque) using the glucan produced. In this plaque, S,
Various microorganisms, including P. mutans, coexist and reproduce, and the metabolism of these microorganisms produces organic acids, which lower the pH of the tooth surface and cause demineralization on the enamel surface. , caries occurs and progresses.
また、歯垢形成は、う蝕のほかに、歯周病や口臭の原因
ともなると考えられている。In addition to dental caries, plaque formation is also thought to be a cause of periodontal disease and bad breath.
[発明が解決しようとする課題]
このような知見に基づき、う蝕予防の方法として、口腔
内微生物の抗菌剤や上記グルコシルトランスフェラーゼ
の阻害剤、またグルコシルトランスフェラーゼがしょ糖
を基質として形成した多糖を分解する酵素について種々
の研究がなされている。しかしながら、未だ満足すべき
効果を有する抗う触法は見い出されていない。[Problems to be Solved by the Invention] Based on this knowledge, as a method of caries prevention, antibacterial agents for oral microorganisms, inhibitors of the above-mentioned glucosyltransferases, and glucosyltransferases that degrade polysaccharides formed using sucrose as a substrate have been proposed. Various studies have been conducted on enzymes that do this. However, no effective countermeasure has yet been found.
特に、S、ミュータンスを中心とする口腔連鎖球菌によ
って形成される歯垢がう蝕の原因となっていることから
、S、ミュータンスのグルコシルトランスフェラーゼ活
性を抑制して歯垢形成を抑えることが、ひいてはう蝕の
発生を予防する有効な手段となりつると考えられている
が、実際に利用しろるようなグルコシルトランスフェラ
ーゼ活性阻害物質が見出されていないのが現状である。In particular, since dental plaque formed by oral streptococci, mainly S. mutans, causes dental caries, it is possible to suppress plaque formation by inhibiting the glucosyltransferase activity of S. mutans. Although it is believed that glucosyltransferase activity can be an effective means for preventing the development of dental caries, no substance that actually inhibits glucosyltransferase activity has been found.
[課題を解決するための手段]
本発明者らは、グルコシルトランスフェラーゼを効果的
に阻害し、がっ、人体に対して有害な作用を有さない物
質を見出すべく鋭意研究を行なった結果、茶葉抽出物中
にS、ミュータンスの産生ずるグルコシルトランスフェ
ラーゼの活性をきわめて有効に阻害する物質が存在する
こと、及びこの物質は合成吸着剤によっても吸着されな
いことを見出し、本発明を完成するにいたった。[Means for Solving the Problems] The present inventors conducted intensive research to find a substance that effectively inhibits glucosyltransferase and does not have harmful effects on the human body. They discovered that there is a substance in the extract that very effectively inhibits the activity of glucosyltransferase that produces S and mutans, and that this substance is not adsorbed even by synthetic adsorbents, leading to the completion of the present invention. .
即ち本発明の第一の目的は、グルコシルトランスフェラ
ーゼ阻害作用を有する茶葉からの抽出物を有効成分とす
る抗う蝕剤を提供することである。That is, the first object of the present invention is to provide an anti-caries agent containing as an active ingredient an extract from tea leaves that has a glucosyltransferase inhibitory effect.
また、本発明の他の目的は、茶葉の溶媒抽出物を合成吸
着剤を用いる吸着処理に付して得られる合成吸着剤非吸
着画分を有効成分として含有する抗う蝕剤を提供するも
のである。Another object of the present invention is to provide an anti-caries agent containing as an active ingredient a fraction not adsorbed to a synthetic adsorbent obtained by subjecting a solvent extract of tea leaves to adsorption treatment using a synthetic adsorbent. be.
更に、本発明の他の目的は、茶葉を溶媒抽出後、該抽出
物を合成吸着剤を用いて吸着処理をし、その非吸着画分
を収得することを特徴とするグルコシルトランスフェラ
ーゼ阻害作用を有する抗う蝕性物質の製造方法を提供す
ることである。Furthermore, another object of the present invention is to obtain a method of inhibiting glucosyltransferase by extracting tea leaves with a solvent and then adsorbing the extract using a synthetic adsorbent to obtain a non-adsorbed fraction. An object of the present invention is to provide a method for producing an anti-cariogenic substance.
本発明の抗う蝕剤の有効成分は、茶葉の抽出物を合成吸
着剤で処理するとき、吸着剤に吸着しない画分(以下、
「非吸着画分」と略称する)に含有されるものである。The active ingredient of the anti-caries agent of the present invention is the fraction that does not adsorb to the adsorbent (hereinafter referred to as
(abbreviated as “non-adsorbed fraction”).
非吸M画分は、茶葉の代表的成分であるカテキン類やカ
フェイン類を全く含まないか、ごく少量しか含まない。The non-absorbed M fraction does not contain catechins or caffeine, which are typical components of tea leaves, or contains only a small amount.
本発明の抗う蝕剤の有効成分であるグルコシルトランス
フェラーゼ阻害作用を有する茶葉抽出物の製造において
、原料として用いる茶葉としては、煎茶、玉露、抹茶等
の不発酵の緑茶、および烏龍茶、紅茶、プアール茶等の
発酵茶の何れをも利用することができるが、不発酵茶の
抽出物は、グルコシルトランスフェラーゼ阻害活性が弱
いため、発酵茶を利用することがより好ましい。In the production of tea leaf extracts having glucosyltransferase inhibitory activity, which is the active ingredient of the anti-caries agent of the present invention, the tea leaves used as raw materials include unfermented green teas such as sencha, gyokuro, and matcha, as well as oolong tea, black tea, and puerh tea. Although any of the fermented teas can be used, it is more preferable to use fermented teas because extracts of unfermented teas have weak glucosyltransferase inhibitory activity.
抽出に用いる溶剤は、水単独もしくは水とメタノール、
エタノール等低級アルコール、アセトン等の1種または
2種以上の極性溶媒との任意の混合物のいずれでもよい
が、極性溶媒だけでは本発明の有効成分を効率よく抽出
できないので、必ず水との混合液とし、かつ、その混合
率は溶媒が90容量%以下であることが好ましい。これ
らの溶剤のうちでは、抽出物等が最終的に口腔用剤や食
品に配合されることを考慮すると、安全性の点で水、エ
タノール、またはこれらの混合物を用いるのが好ましい
。The solvent used for extraction is water alone, water and methanol,
Any mixture with one or more polar solvents such as a lower alcohol such as ethanol or acetone may be used, but since the active ingredient of the present invention cannot be efficiently extracted with a polar solvent alone, it must be a mixture with water. It is preferable that the mixing ratio of the solvent is 90% by volume or less. Among these solvents, it is preferable to use water, ethanol, or a mixture thereof from the viewpoint of safety, considering that the extract and the like will ultimately be incorporated into oral preparations and foods.
抽出に際しての茶葉と溶剤との比率も特に限定されるも
のではないが、茶葉1に対して溶剤2〜1000重量倍
、特に、抽出操作、効率の点で2O−100重量倍が好
ましい。Although the ratio of tea leaves to solvent during extraction is not particularly limited, it is preferably 2 to 1000 times the weight of the solvent to 1 part of the tea leaves, particularly 20-100 times the weight from the point of view of extraction operation and efficiency.
抽出温度は室温〜常圧下での溶剤の沸点の範囲とするの
が便利であり、抽出時間は抽出温度により異なるが、1
0分〜24時間の範囲とするのが好ましい。It is convenient for the extraction temperature to be within the range of room temperature to the boiling point of the solvent under normal pressure, and the extraction time varies depending on the extraction temperature, but
It is preferable to set it as the range of 0 minutes - 24 hours.
このようにして得られた茶葉抽出物から非吸着画分を得
るには、この抽出物を合成吸着剤で処理すれば良い。In order to obtain a non-adsorbed fraction from the tea leaf extract thus obtained, this extract may be treated with a synthetic adsorbent.
茶葉抽出物の分離処理に用いる合成吸着剤とは、スチレ
ンとジビニルベンゼンを重合して製造された芳香族系合
成吸着剤およびメタクリル酸を重合して製造されたメタ
クリル系合成吸着剤で、市販品としては、芳香族系合成
吸着剤ではダイヤイオン■HP20、同HP21(三菱
化成工業)、アンバーライト[F]XAD 2 、同X
AD4(米国、ロームアンドハース社)等が、メタクリ
ル系合成吸着剤ではセパビーズ■HPIMG、同HP2
MG(三菱化成工業)、アンバーライト・XAD7、同
XAD8(米国、ロームアンドハース社)等を挙げるこ
とができる。The synthetic adsorbents used for the separation treatment of tea leaf extracts are aromatic synthetic adsorbents manufactured by polymerizing styrene and divinylbenzene and methacrylic synthetic adsorbents manufactured by polymerizing methacrylic acid. Among the aromatic synthetic adsorbents, Diamondion HP20, Diamondion HP21 (Mitsubishi Chemical Industries), Amberlite [F]XAD 2, Diamondion
AD4 (Rohm and Haas, USA), etc. are used as methacrylic synthetic adsorbents such as Sepabead HPIMG and HP2.
Examples include MG (Mitsubishi Chemical Industries), Amberlite XAD7, and Amberlite XAD8 (Rohm and Haas, USA).
合成吸着剤処理は、好ましくはカラムに当該吸着剤を充
填し、これに茶葉抽出物を通液し、さらに、水で樹脂を
洗浄することにより行われる。The synthetic adsorbent treatment is preferably carried out by filling a column with the adsorbent, passing the tea leaf extract through the column, and washing the resin with water.
茶葉抽出物をこれら合成吸着剤で処理するときは、分画
を完全に行なうために、予め抽出物中の有機溶媒を減圧
濃縮等で除去したり、水で充分希釈する等の前処理を行
なうことが好ましい。When treating tea leaf extracts with these synthetic adsorbents, in order to ensure complete fractionation, pretreatment is performed such as removing the organic solvent in the extract by vacuum concentration, etc., or sufficiently diluting it with water. It is preferable.
叙上の様にして得られた茶葉抽出物および非吸M画分は
、抽出または合成吸着剤処理したそのままのもの、これ
を濃縮したもの、溶出物から溶剤を除去した乾燥物等、
いかなる状態のものでも使用することができるが、保存
性、有機溶媒の安全性の点で乾燥物の状態にするのが好
ましい。The tea leaf extract and non-absorbed M fraction obtained as described above may be extracted or treated with a synthetic adsorbent as is, concentrated, dried after removing the solvent from the eluate, etc.
Although it can be used in any state, it is preferable to use it in a dry state in terms of storage stability and safety of organic solvents.
本発明の抗う蝕剤は、上記の抽出物や非吸着画分を従来
用いられている各種成分と共に配合することにより調製
される。The anti-caries agent of the present invention is prepared by blending the above-mentioned extract and non-adsorbed fraction with various conventionally used ingredients.
本発明抗う蝕剤の好ましい剤形としては、歯磨、洗口液
、トローチ等の口腔用剤が挙げられる他、砂糖等の甘味
料、練りあん、カステラ、水ようかん、どら焼きの皮、
スポンジケーキ、バターケーキ、ババロア、カスタード
クリーム、バタークリーム、カスタードプデイング、ク
ツキー、菓子パン、蒸しパン、ジャム、乳酸菌飲料、炭
酸飲料、コーヒー飲料、コーヒーゼリー、キャラメル、
アイスクリーム、チューインガム、ジュース、キャンデ
イ−、チョコレート等の食品に添加する剤形のものが挙
げられる。これら口腔用剤や食品の製造にはその種類に
応じて通常使用される適宜な成分を使用することができ
、例えば、口腔用剤では炭酸カルシウム、第2リン酸カ
ルシウム、無水ケイ酸、炭酸マグネシウム、グリセリン
、ソルビトール、プロピレングリコール、ポリエチレン
グリコール、カルボキシメチルセルロース、メチルセル
ロース、アルギン酸ソーダ、カラギーナン、カルボキシ
ビニルポリマー、ジオクチルスルホコハク酸ソーダ、ラ
ウリル硫酸ナトリウム、ドデシルベンゼンスルホン酸ナ
トリウム、パラオキシ安息香酸メチル、ヒノキチオール
、アラントイン、グリチルリチン、アルコール、アラビ
アゴム、デンプン、コーンスターチ、サッカリンナトリ
ウム、ステビオサイド、ブドウ糖、乳糖、ステアリン酸
マグネシウム、リン酸2カリウム、リン酸2カリウム、
メントール、ユーカリ油、ペラパーミント、スペアミン
ト、色素等の他、フッ化ナトリウム、モノフルオロリン
酸ナトリウム等のフッ化物、塩化リゾチーム、アズレン
等の抗炎症剤、塩化ナトリウム等を適宜配合することが
できる。Preferred dosage forms of the anti-caries agent of the present invention include oral preparations such as toothpaste, mouthwash, and troches, as well as sweeteners such as sugar, kneaded bean paste, castella cake, water yokan, and dorayaki skin.
Sponge cake, butter cake, bavarois, custard cream, butter cream, custard pudding, kutsky, sweet bread, steamed bread, jam, lactic acid bacteria drink, carbonated drink, coffee drink, coffee jelly, caramel,
Examples include dosage forms added to foods such as ice cream, chewing gum, juice, candy, and chocolate. In the production of these oral preparations and foods, appropriate ingredients that are normally used can be used depending on the type.For example, for oral preparations, calcium carbonate, dicalcium phosphate, silicic anhydride, magnesium carbonate, glycerin , sorbitol, propylene glycol, polyethylene glycol, carboxymethylcellulose, methylcellulose, sodium alginate, carrageenan, carboxyvinyl polymer, sodium dioctylsulfosuccinate, sodium lauryl sulfate, sodium dodecylbenzenesulfonate, methyl paraoxybenzoate, hinokitiol, allantoin, glycyrrhizin, alcohol , gum arabic, starch, cornstarch, sodium saccharin, stevioside, glucose, lactose, magnesium stearate, dipotassium phosphate, dipotassium phosphate,
In addition to menthol, eucalyptus oil, pelapermint, spearmint, pigments, etc., fluorides such as sodium fluoride and sodium monofluorophosphate, anti-inflammatory agents such as lysozyme chloride and azulene, sodium chloride, etc. can be appropriately blended.
また、食品ではブドウ糖、果糖、ショ糖、マルトース、
ソルビトール、ステビオサイド、コーンシロップ、乳糖
、クエン酸、酒石酸、リンゴ酸、コハク酸、乳酸、L−
アスコルビン酸、dl−α−トコフェロール、エリソル
ビン酸ナトリウム、グリセリン、プロピレングリコール
、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エ
ステル、ショ糖脂肪酸エステル、ソルビタン脂肪酸エス
テル、プロピレングリコール脂肪酸エステル、アラビア
ガム、カラギーナン、カゼイン、ゼラチン、ペクチン、
寒天、ビタミンB類、ニコチン酸アミド、パントテン酸
カルシウム、アミノ酸類、カルシウム塩類、色素、香料
、保存剤等、通常の食品原料として使用されているもの
を適宜配合して製造することができる。In addition, food products include glucose, fructose, sucrose, maltose,
Sorbitol, stevioside, corn syrup, lactose, citric acid, tartaric acid, malic acid, succinic acid, lactic acid, L-
Ascorbic acid, dl-α-tocopherol, sodium erythorbate, glycerin, propylene glycol, glycerin fatty acid ester, polyglycerin fatty acid ester, sucrose fatty acid ester, sorbitan fatty acid ester, propylene glycol fatty acid ester, gum arabic, carrageenan, casein, gelatin, pectin,
It can be manufactured by suitably blending those used as ordinary food raw materials, such as agar, B vitamins, nicotinic acid amide, calcium pantothenate, amino acids, calcium salts, pigments, fragrances, and preservatives.
なお、本発明の抗う蝕刻を食品に添加して実施例に示し
た如き抗う触性食品を製造するに際し、砂糖と抗う蝕刻
を添加する場合には、これに替えて後記実施例9〜11
に示したような抗う触性砂糖を利用することも可能であ
る。In addition, when adding the caries-resistant ingredients of the present invention to foods to produce caries-resistant foods as shown in Examples, when adding sugar and the caries-resistant ingredients, Examples 9 to 11 described below may be used instead.
It is also possible to use caries-resistant tactile sugars such as those shown in .
茶は古来より、世界中で広く飲用されており、該抽出物
やこれから得られるその非吸着画分は安全性の点での問
題がないが、本発明の抗う蝕刻における、有効成分の配
合量は、抗う蝕活性の効果および添加した際の味、香り
、色調等の点から乾燥重量換算で、
0.0001〜0.5%の濃度範囲とすることが好まし
い。また、食品中の添加量も、使用時において上記範凹
内とすることが好ましい。Tea has been widely drunk around the world since ancient times, and the extract and its non-adsorbed fraction obtained from it have no safety issues. It is preferable to set the concentration in the range of 0.0001 to 0.5% in terms of dry weight from the viewpoint of anti-caries activity and taste, aroma, color tone, etc. when added. Further, it is preferable that the amount added in foods is also within the above range at the time of use.
[作用及び発明の効果]
従来、カテキン類にはS、ミュータンス:二対して増殖
阻止作用があることが知られているが、その活性はきわ
めて弱く、味覚、臭覚上の面から、実際に使用可能な濃
度ではほとんど抗う蝕活性を期待することはできない。[Action and Effect of the Invention] It has been known that catechins have a growth-inhibiting effect on S. mutans. Little anti-cariogenic activity can be expected at the concentrations available.
しかも、以下の実施例にも示すように、カテキン類やカ
フェインを含まないか、極く少量にしか含まない非吸着
画分にも優れたグルコシルトランスフェラーゼ阻害活性
があることから見て、本発明の効果はカテキン類と関係
ないことは明らかである。Furthermore, as shown in the Examples below, even the non-adsorbed fraction, which does not contain catechins or caffeine or contains only a very small amount, has excellent glucosyltransferase inhibitory activity. It is clear that the effect is not related to catechins.
したがって、本発明の抗う蝕刻はグルコシルトランスフ
ェラーゼ阻害活性を利用した新しいタイプの抗う蝕刻と
して、う歯の予防等に利用することができる。Therefore, the anti-caries engraving of the present invention can be used for the prevention of dental caries, etc. as a new type of anti-caries engraving that utilizes glucosyltransferase inhibitory activity.
特に、有効成分として非吸着画分を利用した場合は、こ
の画分のグルコシルトランスフェラーゼ阻害活性が強く
、しかも特異な味、臭気等がないため、任意の量で抗う
蝕刻に配合することが可能であり、極めて優れた抗う蝕
刻とすることができる。In particular, when a non-adsorbed fraction is used as an active ingredient, this fraction has a strong glucosyltransferase inhibitory activity and has no peculiar taste or odor, so it can be incorporated in any amount into anti-caries agents. It can be used as an extremely effective caries resistant material.
[実施例]
次に該茶葉抽出物およびその非吸着画分の製造法、グル
コシルトランスフェラーゼ阻害活性試験、および抗う蝕
刻の製造に関する実施例を挙げ、本発明を更に詳しく説
明するが、本発明は実施例に限定されるものではない。[Example] Next, the present invention will be explained in more detail by giving examples related to the method for producing the tea leaf extract and its non-adsorbed fraction, glucosyltransferase inhibitory activity test, and production of anti-caries. The examples are not limited.
実施例 1
抽出物の製造例:
烏龍茶100gを2000m1の三角フラスコに入れ、
熱水10100Oを加え、90℃て15分間湯煎して抽
出を行なった。これをセライト濾過し、得た濾液を凍結
乾燥し、抽出物16.5gを得た。Example 1 Extract production example: Put 100g of oolong tea into a 2000ml Erlenmeyer flask,
Hot water of 10,100 O was added and the mixture was boiled at 90° C. for 15 minutes for extraction. This was filtered through Celite, and the obtained filtrate was freeze-dried to obtain 16.5 g of an extract.
紅茶、ブアール茶についても上記と同様にして、それぞ
れ16.4g、17.4gの抽出物を得た。For black tea and Bouar tea, 16.4 g and 17.4 g of extracts were obtained, respectively, in the same manner as above.
実施例2
抽出物の製造例:
烏龍茶100gを2000m1の三角フラスコに入れ、
50容量%エタノール10100Oを加え、室温下て、
1時間毎に軽く撹拌して3時間抽出を行なった。これを
セライト濾過し、得た濾液を減圧上濃縮してエタノール
を除去後、水を加えて凍結乾燥し、抽出物29.2gを
得た。Example 2 Extract production example: Put 100g of oolong tea into a 2000ml Erlenmeyer flask,
Add 10,100 O of 50 volume % ethanol, and at room temperature,
Extraction was performed for 3 hours with gentle stirring every hour. This was filtered through Celite, and the resulting filtrate was concentrated under reduced pressure to remove ethanol, and then water was added and freeze-dried to obtain 29.2 g of an extract.
紅茶、ブアール茶についても上記と同様にして、それぞ
れ30.4g、31.3gの抽出物を得た。For black tea and Bouar tea, 30.4 g and 31.3 g of extracts were obtained, respectively, in the same manner as above.
実施例3
抽出物の製造例:
烏龍茶100gを2000m1の三角フラスコに入れ、
90容量%エタノール10100Oを加え、室温下で、
1時間毎に軽く撹拌して24時間抽出を行なった。これ
をセライト濾過し、得た濾液を減圧上濃縮してエタノー
ルを除去後、水を加えて凍結乾燥し、抽出物1.2gを
得た。Example 3 Extract production example: Put 100g of oolong tea into a 2000ml Erlenmeyer flask,
Add 10,100O of 90% ethanol, and at room temperature,
Extraction was carried out for 24 hours with gentle stirring every hour. This was filtered through Celite, and the resulting filtrate was concentrated under reduced pressure to remove ethanol, and then water was added and freeze-dried to obtain 1.2 g of an extract.
紅茶、プアール茶についても上記と同様にして、それぞ
れ1.4g、1.2gの抽出物を得た。Black tea and Pu'er tea were treated in the same manner as above to obtain 1.4 g and 1.2 g of extracts, respectively.
実施例 4
非吸M画分の製造例:
実施例1の方法に従い得られたウーロン茶抽出物15g
を600m1の水に溶解させ、これをダイヤイオン@H
P21を詰めたカラム(4,4X20cm)に流し、吸
着させた。Example 4 Example of manufacturing non-absorbed M fraction: 15 g of oolong tea extract obtained according to the method of Example 1
Dissolve it in 600ml of water and add it to Diaion@H
It was passed through a column (4.4 x 20 cm) packed with P21 and adsorbed.
吸着剤に吸着しない画分と吸着操作後に21’にの水で
洗浄した洗浄液を合わせて非吸着画分とした。非吸着画
分を減圧濃縮後、凍結乾燥して6.4gの標品を得た。The fraction not adsorbed to the adsorbent and the washing solution washed with water at step 21' after the adsorption operation were combined to form a non-adsorbed fraction. The non-adsorbed fraction was concentrated under reduced pressure and then lyophilized to obtain 6.4 g of a sample.
紅茶、プアール茶についても上記と同様にして、それぞ
れ7.7g、6.3gの非吸着画分を得た。For black tea and Pu'er tea, 7.7 g and 6.3 g of non-adsorbed fractions were obtained, respectively, in the same manner as above.
実施例 5
グルコシルトランスフェラーゼ阻害活
性の検定:
(n素液)
酵素液は、浜田等の方法に従い、S、ミュータンスMT
8148株をトッド−へウィツト(Todd−Hewi
tt)培地で培養し、8M尿素で菌糸から抽出したもの
を用いた( S、Hamadaet、al、、J、Ge
n Microbiol、、135,335−344
(2989)) 。Example 5 Assay of glucosyltransferase inhibitory activity: (N stock solution) Enzyme solutions were prepared using S. mutans MT according to the method of Hamada et al.
8148 shares were purchased by Todd-Hewit.
tt) cultured in medium and extracted from hyphae with 8M urea (S, Hamadaet, al, , J, Ge
n Microbiol, 135, 335-344
(2989)).
(測定法)
5%ショ糖、0.5%デキストラン TlO20,5%
アジ化ナトリウムを含む500mMリン酸ナトリウム緩
衝液(ρ)16.0) 0.6ml、2000ppm
に調製した試料の水溶液液0.15m1、上3己酵素液
及び全量3m1となる■の水を加えて反応系を作成し、
ガラス試験管内で反応させる。この際、酵素量は37°
C13時間の反応で550nmの吸光度が約1.0にな
るように設定する。(Measurement method) 5% sucrose, 0.5% dextran TlO20.5%
500mM sodium phosphate buffer containing sodium azide (ρ) 16.0) 0.6ml, 2000ppm
A reaction system was created by adding 0.15 ml of the aqueous solution of the sample prepared above, the upper 3-enzyme solution, and ① water for a total volume of 3 ml.
React in a glass test tube. At this time, the amount of enzyme was 37°
C The absorbance at 550 nm is set to be approximately 1.0 after 13 hours of reaction.
生成した不溶性グルカンを超音波破砕し、550nmの
吸光度(A)を測定した。試料溌の代わりに水を用いた
ときの吸光度をコントロール(B)として、以下の計算
式で阻害率(%)を求めた。The produced insoluble glucan was disrupted by ultrasonication, and the absorbance (A) at 550 nm was measured. Using the absorbance obtained when water was used instead of the sample as a control (B), the inhibition rate (%) was determined using the following formula.
100X (B−A)
阻害率(%)=□
(測定結果)
以上の反応系を用いて、実施例1.2.3.4で得た各
種茶葉抽出物および茶葉の代表的成分であるカフェイン
、カテキン類のグルコシルトランスフェラーゼ阻害活性
を測定した。100 The glucosyltransferase inhibitory activity of catechins and catechins was measured.
この結果を第1表に示す
(以下余白)
第 1 表
被 検 試 料 阻 害 軍
(%)実施例1の良能茶抽出物
51実施例1の紅茶抽出物
87実施例2の紅茶抽出物
89実施例3の紅茶抽出物
36実施例4の良能茶抽出物の非吸着画分
81実1M倒4の紅茶抽出物
94実旅例4の紅茶抽出物の非吸着画
分 94芙施例4のブアール茶抽出物
74エピガロカテキン
11カ テ キ ン
13エビカテキン
14
エビカテキンガレート
19エピガロカテキンガレート
17実施例6
歯 磨 剤:
(組成) (重量部)第ニリン酸カ
ルシューム 42グリセリン
18カラギーナン 0.9
ラウリル硫酸ナトリウム 1.2サツカリンナ
トリウム 0.09バラオキシ安患香酸ブチル
0.005茶葉抽出物! 0・
05香 料
1全 量
100本実施例1で得られた良能茶葉の抽出物。The results are shown in Table 1 (blank below).
51 Black tea extract of Example 1
87 Black tea extract of Example 2
89 Black tea extract of Example 3
36 Non-adsorbed fraction of the good quality tea extract of Example 4 81 Black tea extract of 1M fruit 4
Non-adsorbed fraction of black tea extract of 94 Example 4 Bouar tea extract of 94 Example 4
74 Epigallocatechin
11 categories
13 shrimp catechin
14 Shrimp catechin gallate
19 Epigallocatechin gallate
17 Example 6 Toothpaste: (Composition) (Parts by weight) Calcium diphosphate 42 Glycerin
18 carrageenan 0.9
Sodium lauryl sulfate 1.2 Sodium saccharin 0.09 Butyl roseoxybenzoate 0.005 Tea leaf extract! 0・
05 fragrance
1 total quantity
100 Extract of the good quality tea leaves obtained in Example 1.
実施例7
洗 口 液:
(組成) (重量部)ラウリル硫酸
ナトリウム 0.8グリセリン
7
ソルビトール 5エチルアルコー
ル 15茶葉抽出物−0,05
1−メントール 0.05香 料
0.04サツカリンナ
トリウム 0.1水
残 量全 量
100車実施例1で得られた紅茶
葉抽出物。Example 7 Mouth rinse: (Composition) (Parts by weight) Sodium lauryl sulfate 0.8 Glycerin
7 Sorbitol 5 Ethyl alcohol 15 Tea leaf extract-0.05 1-Menthol 0.05 Flavor 0.04 Saccharin sodium 0.1 Water
Full amount remaining
Black tea leaf extract obtained in Example 1.
実施例8
トローチ:
(組成) (重量部)アラビアゴム
6フドウW
73茶葉抽出物寡 0.02
リン酸第二カリウム 0.2リン酸第−カリ
ウム 0.1乳 糖
17香 料
0,1ステアリン酸マグネシウ
ム 残 量全 量
100本実施例2で得られたブアール茶葉抽出
物。Example 8 Lozenge: (Composition) (Parts by weight) Gum Arabic 6 Fudo W
73 Tea leaf extract content 0.02
Potassium phosphate 0.2 Potassium phosphate 0.1 Lactose
17 fragrances
0,1 Magnesium Stearate Total amount remaining
100 Bouar tea leaf extract obtained in Example 2.
実施例 9
抗う触性砂糖(粉末)の製造=
(製法)
下記配合の溶液を80〜90℃で加熱溶解し、これを角
形ステンレスハツトに移し、105°Cの乾燥機中て乾
燥させる。乾燥中は、1時間おきにかき混ぜた。乾燥後
、乳鉢ですりつぶし、粉糖の状態に調製した。Example 9 Production of caries-resistant sugar (powder) = (Production method) A solution of the following formulation is heated and dissolved at 80 to 90°C, transferred to a rectangular stainless steel hat, and dried in a dryer at 105°C. During drying, the mixture was stirred every hour. After drying, it was ground in a mortar to prepare powdered sugar.
(配合)
砂 糖 200部茶葉抽出物
1 1部
水 30部*茶葉抽出物と
しては、実施f!A1〜4て得られた玉露、抹茶、良能
茶、紅茶、
ブアール茶抽出物のいずれをも使用で
きる。(Composition) Sugar 200 parts Tea leaf extract 1 1 part Water 30 parts *As a tea leaf extract, implementation f! Any of the gyokuro, matcha, ryono tea, black tea, and bouar tea extracts obtained in A1 to A4 can be used.
実施例 10
抗う触性砂糖(粒状)の製造:
(製法)
下記配合を用い、噴霧造粒機(フローコータマルチ T
L○−5M大大川原作所)により本発明砂糖を噴霧造粒
した。すなわち、原料容器に砂糖を入れ、温風温度90
″Cで約2時間予備乾燥を行なった。この砂糖に、スプ
レーガンにより水に溶解した茶葉抽出物を噴霧しく10
0m1/分;30秒間)、次いて噴霧を止めて20分間
中間乾燥を行なった。噴霧、中間乾燥を4回繰り返した
後、仕上げ乾燥を20分おこない、更に冷却を20分間
行ない抗う触性砂糖を得た。Example 10 Production of caries-resistant sugar (granular): (Production method) Using the following formulation, a spray granulator (Flow Coater Multi T
The sugar of the present invention was spray granulated using L○-5M Ookawa Original Manufacturing Co., Ltd.). In other words, put sugar in a raw material container and heat air at a temperature of 90.
Pre-drying was carried out for about 2 hours at "C". Tea leaf extract dissolved in water was sprayed onto the sugar using a spray gun for 10 minutes.
0 m1/min; 30 seconds), then the spraying was stopped and intermediate drying was performed for 20 minutes. After repeating spraying and intermediate drying four times, final drying was performed for 20 minutes, and cooling was further performed for 20 minutes to obtain a tactile sugar with resistance.
(配合)
砂 糖 200部茶葉抽出物8
1部
水 10部
*茶葉抽出物としては、実施例1〜4
で得られた玉露、抹茶、良能茶、紅茶、ブアール茶抽出
物のいずれをも使用で
きる。(Composition) Sugar 200 parts Tea leaf extract 8
1 part water 10 parts *As the tea leaf extract, any of the gyokuro, matcha, ryono tea, black tea, and bouar tea extracts obtained in Examples 1 to 4 can be used.
実施例 11
抗う触性砂糖(シロップ)の製造:
(製法 )
熱水50部に0.75部の茶葉抽出物を加え、溶解し、
この溶液に砂1!150部を加えて本発明の抗う触性砂
糖(シロップ)を得る。Example 11 Production of anti-cariogenic sugar (syrup): (Production method) Add 0.75 parts of tea leaf extract to 50 parts of hot water and dissolve.
1.150 parts of sand is added to this solution to obtain the anticorrosive sugar (syrup) of the present invention.
茶葉抽出物としては、実施例1〜2で得られた玉露、抹
茶、良能茶、紅茶、ブアール茶抽出物のいずれをも使用
できる。As the tea leaf extract, any of the gyokuro, matcha, ryono tea, black tea, and bouar tea extracts obtained in Examples 1 and 2 can be used.
上記実施例9〜11で得られる如き抗う触性@糖は、砂
糖と抗う蝕性物質の比が砂糖1000部に対し、抗う蝕
剤0,1〜10部程度とすることが好ましい。In the cariogenic @sugar obtained in Examples 9 to 11 above, the ratio of sugar to cariogenic substance is preferably about 0.1 to 10 parts of the cariogenic agent per 1000 parts of sugar.
実施例 12
抗う触性甘味料の甘味度比較:
本発明の抗う触性砂糖の甘味度を砂糖およびパラチノー
スと以下のように官能評価により比較した。Example 12 Comparison of sweetness of caries-resistant sweeteners: The sweetness of the caries-resistant sugar of the present invention was compared with sugar and palatinose by sensory evaluation as follows.
(試験サンプル) 本発明抗う触性砂糖; 実施例1においてウーロン茶抽出物を使用したもの。(Test sample) Anti-cariogenic sugar of the present invention; Example 1 using oolong tea extract.
砂 糖 : 上 白 糖パラチノー
ス ; 結晶パラチノース
(評価方法)
砂糖5%溶液を作成し、これをコントロールとした。Sugar: Super white sugar Palatinose: Crystalline palatinose (evaluation method) A 5% sugar solution was prepared and used as a control.
抗う触性砂糖は3%、4%、5%、6%、7%溶液を作
成し、パラチノースは6%、8%、10%、12%、1
4%溶液を作成し、10人のパネラ−に室温で2点識別
法で官能評価を行ない、砂糖5%溶液と同じ甘味度に相
当する抗う触性砂糖溶液とパラチノース溶液を検討した
。Anti-caries sugar makes 3%, 4%, 5%, 6%, 7% solutions, and palatinose makes 6%, 8%, 10%, 12%, 1
A 4% solution was prepared, and 10 panelists conducted a sensory evaluation at room temperature using the two-point discrimination method to examine cariogenic sugar solutions and palatinose solutions that had the same sweetness as a 5% sugar solution.
その結果を第2表に示す。The results are shown in Table 2.
第 2 表
サンプル名 甘味度
砂 @ 1.0抗う蝕性
砂1i 1.0
パラチノース 0・4
この結果から、本発明の抗う触性砂糖は砂糖と同等の甘
味度を示すが、抗う触性砂糖代替品であるパラチノース
は砂糖の半分以下の甘味度しか示さないことがわかる。Table 2 Sample name Sweetness sand @ 1.0 Anti-caries sand 1i 1.0 Palatinose 0.4 From these results, the anti-caries sugar of the present invention shows the same sweetness as sugar, but the anti-caries sugar It can be seen that the substitute, palatinose, has less than half the sweetness of sugar.
実施例 13
抗う触性砂糖の溶解性:
砂糖、抗う触性砂糖およびパラチノースの水に対する溶
解性を以下のように溶解度で比較した。Example 13 Solubility of anti-caries sugar: The solubility of sugar, anti-caries sugar and palatinose in water was compared in terms of solubility as follows.
(試験サンプル)
本発明の抗う触性砂糖;
実施例1において、ウーロン茶抽出物を用いたもの
砂 糖 ; 上白糖
パラチノース ; 結晶パラチノース
(評価方法)
10°C130℃、50℃、70℃において蒸留水に砂
糖、抗う触性砂糖およびパラチノースを各々完全に溶解
するまで添加した。(Test sample) Anti-cavity sugar of the present invention; Oolong tea extract used in Example 1 Sugar; Super sugar Palatinose; Crystalline Palatinose (Evaluation method) Distilled water at 10°C, 130°C, 50°C, and 70°C Sugar, anti-caries sugar and palatinose were each added until completely dissolved.
その時の各温度別溶解度を第3表に示す。Table 3 shows the solubility at each temperature at that time.
第 3 表
10℃30℃50℃70”C
砂 W 63 68 72
74抗う触性甘味料 63 68 72
74パラチノース 21 32 44
58この結果から明らかなように、本発明の抗う触性
砂糖は砂糖と同じ溶解度を示す。Table 3 10℃30℃50℃70”C Sand W 63 68 72
74 Anti-cariogenic sweeteners 63 68 72
74 Palatinose 21 32 44
58 As is clear from this result, the caries-resistant sugar of the present invention exhibits the same solubility as sugar.
これに対し、抗う触性砂糖代替品の代表であるパラチノ
ースは特に低温下での溶解性が悪いので、本発明の抗う
触性砂糖がパラチノースと比べ利用しやすいことは明ら
かである。On the other hand, since palatinose, which is a typical caries-resistant sugar substitute, has poor solubility especially at low temperatures, it is clear that the caries-resistant sugar of the present invention is easier to use than palatinose.
したがって、本発明の抗う蝕砂糖は、特に低温の食品、
例えばアイスクリーム、氷菓子等や低温においての保存
が要求される食品において有利に利用することができる
。Therefore, the anti-caries sugar of the present invention is suitable for low temperature foods, especially
For example, it can be advantageously used in ice cream, frozen sweets, and other foods that require storage at low temperatures.
実施例 14
抗う触性試験:
砂糖(上白糖)、抗う触性砂糖(実施例9)およびパラ
チノース(結晶パラチノース)の3試料について、それ
らのグルカン生成量を下記方法で比較した。すなわち、
10%の試料溜?e!0 、3 m l、1,0%デキ
ストランTl011.0% アジ化ナトリウムを含む1
00mMリン酸ナトリウム緩衝液(pH6,0)0.3
mlおよびグルコシルトランスフェラーゼ酵素液に全量
3mlとなる量の水を加えて反応系を作成し、ガラス試
験管内で反応させる。この際、酵素量は試料として砂糖
(上白糖)を使用し、37°Cで3時間反応させたとき
に、550nmの吸光度が約1.0になるように設定す
る。Example 14 Anti-caries test: Three samples of sugar (superfine sugar), anti-caries sugar (Example 9), and palatinose (crystalline palatinose) were compared for their glucan production amounts using the following method. That is,
10% sample reservoir? e! 0,3 ml, 1,0% dextran Tl01 containing 1.0% sodium azide
00mM sodium phosphate buffer (pH 6,0) 0.3
A reaction system is prepared by adding water to a total volume of 3 ml to ml and glucosyltransferase enzyme solution, and the reaction is carried out in a glass test tube. At this time, the amount of enzyme is set so that the absorbance at 550 nm is approximately 1.0 when sugar (white sugar) is used as a sample and reacted for 3 hours at 37°C.
生成した不溶性グルカンを超音波破砕し、550nmの
吸光度(A)を測定した。被検サンプルとして砂糖を用
いたときの吸光度をコントロール(B)として、以下の
計算式て生成グルカンの砂糖に対する相対量(%)を求
めた。この結果を第4表に示す。The produced insoluble glucan was disrupted by ultrasonication, and the absorbance (A) at 550 nm was measured. Using the absorbance when sugar was used as a test sample as a control (B), the relative amount (%) of produced glucan to sugar was determined using the following formula. The results are shown in Table 4.
100 X A
生成グルカンの相対!(%)=
なお、グルコシルトランスフェラーゼ酵、素液は、S、
ミュータンスMT8148株をトッドーヘーウイット(
Todd−Hewitt )培地で培養し、8モル尿素
で菌体から抽出したものを用いた(S、Hamada
et、al、J、Gen、Microbiol。100 X A Relative of produced glucan! (%) = Glucosyltransferase enzyme, base solution is S,
mutans MT8148 stock to Todd Hoewit (
Todd-Hewitt) medium and extracted from the bacterial cells with 8 molar urea (S, Hamada).
et,al,J,Gen,Microbiol.
135.335−344.(1989) ’)。135.335-344. (1989)').
(結果)
第 4 表
試 料 名 生成グルカン相対量
(%)
砂! (コントロール) 10
0抗う触性砂糖 6
パラチノース 2
この結果から明らかなように、本発明の抗う触性砂糖は
、砂糖をその主要成分としながら、砂糖に比較してグル
カンは生成しにくく、パラチノースに近いグルカン生成
抑制作用を有していることが明らかである。(Results) Table 4 Sample name Relative amount of glucan produced (%) Sand! (control) 10
0 Anti-caries sugar 6 Palatinose 2 As is clear from these results, although the anti-caries sugar of the present invention has sugar as its main component, it is less likely to produce glucan compared to sugar, and is similar to palatinose in suppressing glucan production. It is clear that it has an effect.
実施例 15
抗う触性試験:
砂糖(上白糖)、抗う触性砂糖(実施例9において良能
茶抽出物を用いたもの)およびパラチノース(結晶パラ
チノース)について、試註管内での歯垢(プラーク)形
成試験を行なった。試験は、ダルベツコ変法イーグル培
地に5%の各試験サンプルを添加したものを培地とし、
ガラス試験管にこの培地を6ml加え、S、ミュータン
ス MT8148株を植菌した。嫌気条件下で37°C
11日培養した後、試験管壁に付着した歯垢形成量を測
定した。この結果を第5表に示す。Example 15 Anti-cariogenic property test: For sugar (white sugar), anti-cariogenic sugar (using high-grade tea extract in Example 9) and palatinose (crystalline palatinose), dental plaque (plaque) was tested in a test tube. ) A formation test was conducted. For the test, the medium was Dulbecco's modified Eagle's medium to which 5% of each test sample was added.
6 ml of this medium was added to a glass test tube, and S. mutans MT8148 strain was inoculated. 37°C under anaerobic conditions
After culturing for 11 days, the amount of plaque formed on the test tube wall was measured. The results are shown in Table 5.
(結果)
第 5 表
試 料 歯垢形成量
(mg)
砂 fi 25.62 ± 1.7
8”抗う触性砂糖 3.21 ± 0.54”パラ
チノース 2.01 ± 0.22”8平均値士標
準偏差
実施例 16
ガ ム :
(組成) (重量部)ガムペース
20炭酸カルシウム
2ステビオサイド 0.1
茶葉抽出物” 0.01乳
1i 76.89全
量 100*
実施例3て得られた良能茶抽出物。(Results) Table 5 Sample Amount of plaque formation (mg) Sand fi 25.62 ± 1.7
8” Anti-caries sugar 3.21 ± 0.54” Palatinose 2.01 ± 0.22” 8 Mean value Standard deviation Example 16 Gum: (Composition) (Parts by weight) Gum paste
20 calcium carbonate
2 Stevioside 0.1
Tea leaf extract” 0.01 milk
1i 76.89 total
Amount 100*
Liangno tea extract obtained in Example 3.
実施例17
ジユース:
(組成) (重量部)冷凍濃縮温州
みかん果汁 5果糖ブドウ糖液糖
11クエン酸 0.2
L−アスコルビン酸 0.02非吸着画分”
0.01香 料
0.2色 素
0.1水
残 置傘 量
100*実施例4で得ら
れた紅茶葉抽出物の非吸着画分。Example 17 Youth: (Composition) (Parts by weight) Frozen concentrated unshiu mandarin juice 5-fructose glucose liquid sugar
11 Citric acid 0.2
L-ascorbic acid 0.02 non-adsorbed fraction”
0.01 fragrance
0.2 dye
0.1 water
Amount of remaining umbrellas
100*Non-adsorbed fraction of black tea leaf extract obtained in Example 4.
実施例18
飴:
(組成) (重量部)粉末ソルビト
ール 99.745香 料
0.2昇級着画分”
0.005ソルビトールシード
0.05全 量
100*実施例4で得られたブアール茶葉抽出物
の非吸着画分。Example 18 Candy: (Composition) (Parts by weight) Powdered sorbitol 99.745 Flavor
0.2 promotion fraction”
0.005 sorbitol seeds
0.05 total amount
100*Non-adsorbed fraction of Bouar tea leaf extract obtained in Example 4.
手続補正書(自発) 平成3年4月15日Procedural amendment (voluntary) April 15, 1991
Claims (1)
茶葉からの抽出物を有効成分とする抗う蝕剤。 (2)グルコシルトランスフェラーゼ阻害作用を有する
茶葉からの抽出物を、 0.0001〜0.5%含有する請求項第1項記載の抗
う蝕剤。 (3)グルコシルトランスフェラーゼ阻害作用を有する
茶葉からの抽出物を有効成分とする口腔衛生剤。 (4)グルコシルトランスフェラーゼ阻害作用を有する
茶葉からの抽出物を有効成分とする食品。 (5)茶葉の溶媒抽出物を合成吸着剤を用いる吸着処理
に付して得られる合成吸着剤非吸着画分を有効成分とし
て含有する抗う蝕剤。 (6)合成吸着剤非吸着画分の含量が0.0001〜0
.5%である請求項第5項記載の抗う蝕剤。 (7)茶葉の溶媒抽出物を合成吸着剤を用いる吸着処理
に付して得られる合成吸着剤非吸着画分を有効成分とし
て含有する口腔衛生剤。 (8)茶葉の溶媒抽出物を合成吸着剤を用いる吸着処理
に付して得られる合成吸着剤非吸着画分を有効成分とし
て含有する食品。 (9)茶葉を溶媒抽出後、該抽出物を合成吸着剤を用い
て吸着処理をし、その非吸着画分を収得することを特徴
とするグルコシルトランスフェラーゼ阻害作用を有する
抗う蝕性物質の製造方法。 (10)請求項第9項記載の製造方法において、茶葉が
醗酵茶であることを特徴とするグルコシルトランスフェ
ラーゼ阻害作用を有する抗う蝕性物質の製造方法。[Scope of Claims] (1) An anti-caries agent containing as an active ingredient an extract from tea leaves that has a glucosyltransferase inhibitory effect. (2) The anti-caries agent according to claim 1, which contains 0.0001 to 0.5% of an extract from tea leaves having a glucosyltransferase inhibitory effect. (3) An oral hygiene agent whose active ingredient is an extract from tea leaves that has a glucosyltransferase inhibitory effect. (4) A food whose active ingredient is an extract from tea leaves that has a glucosyltransferase inhibitory effect. (5) An anti-caries agent containing as an active ingredient a synthetic adsorbent-unadsorbed fraction obtained by subjecting a solvent extract of tea leaves to adsorption treatment using a synthetic adsorbent. (6) Content of non-adsorbed fraction of synthetic adsorbent is 0.0001 to 0
.. The anti-caries agent according to claim 5, wherein the amount is 5%. (7) An oral hygiene agent containing as an active ingredient a synthetic adsorbent-unadsorbed fraction obtained by subjecting a solvent extract of tea leaves to adsorption treatment using a synthetic adsorbent. (8) A food product containing as an active ingredient a synthetic adsorbent-unadsorbed fraction obtained by subjecting a solvent extract of tea leaves to adsorption treatment using a synthetic adsorbent. (9) A method for producing an anti-cariogenic substance having a glucosyltransferase inhibitory effect, which comprises extracting tea leaves with a solvent, adsorbing the extract using a synthetic adsorbent, and obtaining the non-adsorbed fraction. . (10) The method for producing an anti-caries substance having a glucosyltransferase inhibiting effect, wherein the tea leaves are fermented tea.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2301200A JPH0763294B2 (en) | 1990-03-30 | 1990-11-08 | Anti-cariogenic food |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8078890 | 1990-03-30 | ||
JP2-202500 | 1990-08-01 | ||
JP2-80788 | 1990-08-01 | ||
JP20250090 | 1990-08-01 | ||
JP2301200A JPH0763294B2 (en) | 1990-03-30 | 1990-11-08 | Anti-cariogenic food |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1993345869A Division JP2784627B6 (en) | 1990-03-30 | 1993-12-24 | Anti-caries agent, anti-cariogenic food and method for producing anti-caries agent |
JP5345868A Division JPH06263646A (en) | 1990-03-30 | 1993-12-24 | Cariostatic agent |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04178320A true JPH04178320A (en) | 1992-06-25 |
JPH0763294B2 JPH0763294B2 (en) | 1995-07-12 |
Family
ID=26421761
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2301200A Expired - Lifetime JPH0763294B2 (en) | 1990-03-30 | 1990-11-08 | Anti-cariogenic food |
JP5345868A Pending JPH06263646A (en) | 1990-03-30 | 1993-12-24 | Cariostatic agent |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5345868A Pending JPH06263646A (en) | 1990-03-30 | 1993-12-24 | Cariostatic agent |
Country Status (2)
Country | Link |
---|---|
JP (2) | JPH0763294B2 (en) |
CA (1) | CA2039538C (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6297273B1 (en) | 1996-04-02 | 2001-10-02 | Mars, Inc. | Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions |
US6423743B1 (en) | 1996-04-02 | 2002-07-23 | Mars Incorporated | Cocoa extract compounds and methods for making and using the same |
US6469053B1 (en) | 1996-04-02 | 2002-10-22 | Mars Incorporated | Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response |
US6855352B2 (en) | 2000-09-12 | 2005-02-15 | The Nikka Whisky Distilling Co., Ltd. | Wild apple polyphenol and process for producing the same |
JP2009517352A (en) * | 2005-11-25 | 2009-04-30 | ズートツッカー アクチェンゲゼルシャフト マンハイム/オクセンフルト | Preparation comprising polyphenol-containing composition and isomaltulose |
JP4585066B2 (en) * | 1999-10-19 | 2010-11-24 | 丸善製薬株式会社 | Caries inhibitor, oral preparation and food and drink |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060141039A1 (en) | 2004-12-23 | 2006-06-29 | Colgate-Palmolive Company | Oral compositions containing oxidized camellia |
TW200812637A (en) * | 2006-09-15 | 2008-03-16 | jun-er Wang | Vegetable composition for cleaning oral cavity |
JP5563753B2 (en) * | 2008-08-29 | 2014-07-30 | サントリーホールディングス株式会社 | Glucosyltransferase inhibitor containing epigallocatechin gallate polymer as active ingredient |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6013780A (en) * | 1983-07-05 | 1985-01-24 | Mitsui Norin Kk | Production of tea catechin compound |
JPS649922A (en) * | 1987-07-02 | 1989-01-13 | Taiyo Kagaku Kk | Teeth-decay and periodental disease-resisting composition |
JPH0386814A (en) * | 1989-08-30 | 1991-04-11 | Mitsui Norin Kk | Plaque formation inhibitor |
-
1990
- 1990-11-08 JP JP2301200A patent/JPH0763294B2/en not_active Expired - Lifetime
-
1991
- 1991-04-02 CA CA002039538A patent/CA2039538C/en not_active Expired - Lifetime
-
1993
- 1993-12-24 JP JP5345868A patent/JPH06263646A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6013780A (en) * | 1983-07-05 | 1985-01-24 | Mitsui Norin Kk | Production of tea catechin compound |
JPS649922A (en) * | 1987-07-02 | 1989-01-13 | Taiyo Kagaku Kk | Teeth-decay and periodental disease-resisting composition |
JPH0386814A (en) * | 1989-08-30 | 1991-04-11 | Mitsui Norin Kk | Plaque formation inhibitor |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6297273B1 (en) | 1996-04-02 | 2001-10-02 | Mars, Inc. | Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions |
US6423743B1 (en) | 1996-04-02 | 2002-07-23 | Mars Incorporated | Cocoa extract compounds and methods for making and using the same |
US6469053B1 (en) | 1996-04-02 | 2002-10-22 | Mars Incorporated | Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response |
US6638971B2 (en) | 1996-04-02 | 2003-10-28 | Mars, Incorporated | Cocoa extract compounds and methods for making and using the same |
US6670390B1 (en) | 1996-04-02 | 2003-12-30 | Mars Incorporated | Cocoa extract compounds and methods for making and using the same |
US6747059B1 (en) | 1996-04-02 | 2004-06-08 | Mars, Incorporated | Composition for, and methods of, anti-platelet therapy |
US8377424B2 (en) | 1996-04-02 | 2013-02-19 | Mars, Incorporated | Treatment of periodontal disease |
JP4585066B2 (en) * | 1999-10-19 | 2010-11-24 | 丸善製薬株式会社 | Caries inhibitor, oral preparation and food and drink |
US6855352B2 (en) | 2000-09-12 | 2005-02-15 | The Nikka Whisky Distilling Co., Ltd. | Wild apple polyphenol and process for producing the same |
JP2009517352A (en) * | 2005-11-25 | 2009-04-30 | ズートツッカー アクチェンゲゼルシャフト マンハイム/オクセンフルト | Preparation comprising polyphenol-containing composition and isomaltulose |
Also Published As
Publication number | Publication date |
---|---|
CA2039538A1 (en) | 1991-10-01 |
JPH06279302A (en) | 1994-10-04 |
CA2039538C (en) | 2002-03-12 |
JP2784627B2 (en) | 1998-08-06 |
JPH06263646A (en) | 1994-09-20 |
JPH0763294B2 (en) | 1995-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPWO2003094878A1 (en) | Gallocatechin gallate-containing composition | |
US5409692A (en) | Glucosyltransferase inhibitors, as well as dental caries prevention methods and anticarious foods using the same | |
KR20090080088A (en) | Noncarious material and anticarious agent containing rare sugar | |
JP3579496B2 (en) | Tea extract or tea beverage with reduced astringency and method for producing the same | |
JP4397142B2 (en) | Reactive oxygen scavenging reduction inhibitor | |
JP2009084214A (en) | Glycation inhibitor | |
JP2000256345A (en) | Production of polyphenol compounds | |
JPH04178320A (en) | Production of anticariogenic agent and anticariogenic substance and anticariogenic food containing the same | |
US20070218189A1 (en) | Reduction inhibitory agent for active oxygen eliminating-activity | |
JP3254553B2 (en) | Anti-caries material, its production method and use | |
JP3014128B2 (en) | Method for producing anti-cariogenic agent and anti-cariogenic substance | |
JPH07242555A (en) | Glucosyl transferase-inhibiting agent and dental caries-resistant agent and dental caries-resistant food containing the same as active ingredient | |
JP4669683B2 (en) | Antibacterial composition | |
JP2004002620A (en) | Aroma retaining method and use thereof | |
JP3465039B2 (en) | Plaque formation inhibitor and its use | |
JP2784627B6 (en) | Anti-caries agent, anti-cariogenic food and method for producing anti-caries agent | |
Sakanaka | Green tea polyphenols for prevention of dental caries | |
JPH03284625A (en) | Production of cariostatic substance and use thereof | |
JP5766173B2 (en) | Foods and drinks containing chlorogenic acids | |
JPH03284671A (en) | Enhancement of glucosyltransferase-inhibitory activity | |
JP2887696B2 (en) | Glucosyltransferase inhibitors and oral cleansing agents | |
JPH04134026A (en) | Composition for oral cavity | |
JPH0753398A (en) | Glucosyl transferase-inhibiting agent | |
JPH04290831A (en) | New substance af90-nf and glucosyltransferase inhibitor | |
JPH07242556A (en) | Dental caries-resistant lavonoid polymer and glucosyl transferase-inhibiting agent and food containing the same active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080712 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080712 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090712 Year of fee payment: 14 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090712 Year of fee payment: 14 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090712 Year of fee payment: 14 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090712 Year of fee payment: 14 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100712 Year of fee payment: 15 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110712 Year of fee payment: 16 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110712 Year of fee payment: 16 |